Clinical Trials Browser

Phase 2 × Terminated × BID protein, human × Clear all

NCT04515979 2024-12-09

Vactosertib in Combination with Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) Subjects

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02101684 2018-03-05

Greko II

Phase 2 Terminated

Granulosa Cell Tumor, Neoplasm Metastasis